The role of individual inheritance in tumor progression and metastasis

Journal of Molecular Medicine

Volumn 93, Issue 7, 2015, Pages 719-725

  Hunter, Kent ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer related deaths; Metastasis; Solid tumors

Indexed keywords

PROTEIN; PROTEIN RRP1B; PROTEIN SIPA1; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NONHISTONE PROTEIN; NUCLEAR PROTEIN; RRP1B PROTEIN, HUMAN; SIPA1 PROTEIN, MOUSE;

AMINO ACID SUBSTITUTION; BREAST CANCER; BREAST METASTASIS; CANCER PROGNOSIS; CELL HETEROGENEITY; CELL MIGRATION; COLORECTAL CANCER; DISTANT METASTASIS FREE SURVIVAL; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INHERITANCE; LUNG CANCER; METASTASIS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR GROWTH; UTERINE CERVIX CANCER; ANIMAL; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; MORTALITY; MOUSE; NEOPLASM; PATHOLOGY;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CHROMOSOMAL PROTEINS, NON-HISTONE; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GTPASE-ACTIVATING PROTEINS; HUMANS; MICE; NEOPLASM METASTASIS; NEOPLASMS; NUCLEAR PROTEINS;

EID: 84931572031     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-015-1299-6     Document Type: Review

References (46)

1. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23–28
2. Harris JF, Chambers AF, Hill RP, Ling V (1982) Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor. Proc Natl Acad Sci U S A 79:5547–5551
3. Weiss L (1990) Metastatic inefficiency. Adv Cancer Res 54:159–211
4. Pawelek JM (2005) Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 6:988–993
5. Garcia-Olmo D, Garcia-Olmo DC, Ontanon J, Martinez E, Vallejo M (1999) Tumor DNA circulating in the plasma might play a role in metastasis. The hypothesis of the genometastasis. Histol Histopathol 14:1159–1164
6. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C et al (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18:883–891
7. Bernards R, Weinberg RA (2002) A progression puzzle. Nature 418:823
8. Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW (2009) Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. Breast Cancer Res 11:R75
9. Talmadge JE, Wolman SR, Fidler IJ (1982) Evidence for the clonal origin of spontaneous metastases. Science 217:361–363
10. Haffner MC, Mosbruger T, Esopi DM, Fedor H, Heaphy CM, Walker DA, Adejola N, Gurel M, Hicks J, Meeker AK et al (2013) Tracking the clonal origin of lethal prostate cancer. J Clin Invest 123:4918–4922
11. Lee SY, Haq F, Kim D, Jun C, Jo HJ, Ahn SM, Lee WS (2014) Comparative genomic analysis of primary and synchronous metastatic colorectal cancers. PLoS ONE 9, e90459. doi:10.1371/journal.pone.0090459
12. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J et al (2009) Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461:809–813
13. Huang Y, Gao S, Wu S, Song P, Sun X, Hu X, Zhang S, Yu Y, Zhu J, Li C et al (2014) Multilayered molecular profiling supported the monoclonal origin of metastatic renal cell carcinoma. Int J Cancer 135:78–87
14. Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL et al (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464:999–1005
15. Turajlic S, Furney SJ, Stamp G, Rana S, Ricken G, Oduko Y, Saturno G, Springer C, Hayes A, Gore M et al (2014) Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition. Ann Oncol 25:959–967
16. Zhang XC, Xu C, Mitchell RM, Zhang B, Zhao D, Li Y, Huang X, Fan W, Wang H, Lerma LA et al (2013) Tumor evolution and intratumor heterogeneity of an oropharyngeal squamous cell carcinoma revealed by whole-genome sequencing. Neoplasia 15:1371–1378
17. Xie T, Cho YB, Wang K, Huang D, Hong HK, Choi YL, Ko YH, Nam DH, Jin J, Yang H et al (2014) Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing. Genomics 104:234–241
18. Blighe K, Kenny L, Patel N, Guttery DS, Page K, Gronau JH, Golshani C, Stebbing J, Coombes RC, Shaw JA (2014) Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodes. PLoS ONE 9:e115346
19. Kitamura T, Qian BZ, Pollard JW (2015) Immune cell promotion of metastasis. Nat Rev Immunol 15:73–86
20. Ko JS, Bukowski RM, Fincke JH (2009) Myeloid-derived suppressor cells: a novel therapeutic target. Curr Oncol Rep 11:87–93
21. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, Klemm A, Flicek P, Manolio T, Hindorff L et al (2014) The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42:D1001–D1006
22. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. MCB 12:954–961
23. Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, Buetow KH, Hunter KW (1998) Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 77:640–644
24. Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, Debies MT, Rouse J, Welch DR (2001) Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res 61:8866–8872
25. Park YG, Clifford R, Buetow KH, Hunter KW (2003) Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes. Genome Res 13:118–121
26. Park YG, Zhao X, Lesueur F, Lowy DR, Lancaster M, Pharoah P, Qian X, Hunter KW (2005) Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet 37:1055–1062
27. Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW (2006) Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res 8:R16
28. Zhang Y, Gong Y, Hu D, Zhu P, Wang N, Zhang Q, Wang M, Aldeewan A, Xia H, Qu X et al (2014) Nuclear SIPA1 activates integrin beta1 promoter and promotes invasion of breast cancer cells. Oncogene. doi:10.1038/onc.2014.36
29. Roberts MR, Hong CC, Edge SB, Yao S, Bshara W, Higgins MJ, Freudenheim JL, Ambrosone CB (2013) Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival. Breast Cancer Res Treat 139:873–885
30. Pei R, Xu Y, Wei Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y (2013) Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer. Front Med 7:138–142
31. Xie C, Yang L, Yang X, Yang R, Li Y, Qiu F, Chen M, Fang W, Bin X, Deng J et al (2013) Sipa1 promoter polymorphism predicts risk and metastasis of lung cancer in Chinese. Mol Carcinog 52(Suppl 1):E110–E117
32. Brooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE, Rader JS (2010) Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer. Gynecol Oncol 116:539–543
33. Hartman M, Lindstrom L, Dickman PW, Adami HO, Hall P, Czene K (2007) Is breast cancer prognosis inherited? Breast Cancer Res 9:R39
34. Hemminki K, Ji J, Forsti A, Sundquist J, Lenner P (2008) Survival in breast cancer is familial. Breast Cancer Res Treat 110:177–182
35. Verkooijen HM, Hartman M, Usel M, Benhamou S, Neyroud-Caspar I, Czene K, Vlastos G, Chappuis PO, Bouchardy C, Rapiti E (2012) Breast cancer prognosis is inherited independently of patient, tumour, and treatment characteristics. Int J Cancer. doi:10.1002/ijc.26206
36. Hemminki K, Ji J, Forsti A, Sundquist J, Lenner P (2008) Concordance of survival in family members with prostate cancer. J Clin Oncol 26:1705–1709
37. Lindstrom LS, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K (2007) Familial concordance in cancer survival: a Swedish population-based study. Lancet Oncol 8:1001–1006
38. Ji J, Forsti A, Sundquist J, Lenner P, Hemminki K (2008) Survival in bladder and renal cell cancers is familial. J Am Soc Nephrol. doi:10.1681/ASN.2007070818
39. Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes L, Rowe WL, Zhang J, Ambs S et al (2007) Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 3:e214
40. Hunter KW, Welch DR, Liu ET (2003) Genetic background is an important determinant of metastatic potential. Nat Genet 34:23–24
41. Lukes L, Crawford NP, Walker R, Hunter KW (2009) The origins of breast cancer prognostic gene expression profiles. Cancer Res 69:310–318
42. Faraji F, Pang Y, Walker RC, Nieves Borges R, Yang L, Hunter KW (2012) Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunity. PLoS Genet 8:e1002926
43. Crawford NP, Walker RC, Lukes L, Officewala JS, Williams RW, Hunter KW (2008) The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival. Clin Exp Metastasis 25:357–369
44. Crawford NP, Alsarraj J, Lukes L, Walker RC, Officewala JS, Yang HH, Lee MP, Ozato K, Hunter KW (2008) Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci U S A 105:6380–6385
45. Winter SF, Lukes L, Walker RC, Welch DR, Hunter KW (2012) Allelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis. PLoS Genet 8:e1002735
46. Faraji F, Hu Y, Wu G, Goldberger NE, Walker RC, Zhang J, Hunter KW (2014) An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease. Genome Res 24:227–240